Events

Horizon 2020 no financial errors info session
APR
Tue
02
07:00 - 14:00

This was 6 years ago

Location

Bip.brussels



Koningsstraat 2-4



1000 Brussel


Programmes
H2020 L+F

This information session is organised by the European Commission in close cooperation with the Belgian Legal and Financial National Contact Points.

The aim of the event is to explain to Horizon2020 project partners how to avoid errors in Horizon 2020 project reporting.

Topics such as personnel costs, other direct costs, third parties, lumps sum grants will be covered during this whole day event.

Deadline for registration: 25 March

For more information and registration please visit the event website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.